Tuberculosis illness (TB), brought on by Mycobacterium tuberculosis, is a serious public well being concern in Thailand. The excessive prevalence of recent Beijing (Lineage 2.2.1) strains has been related to multi- and extensively-drug resistant infections (MDR-, XDR-TB), complicating illness management. The affect of rarer proto-Beijing (L2.1) strains is much less clear. In our research of thirty-seven L2.1 scientific isolates spanning 13 years, we discovered a excessive prevalence of XDR-TB circumstances (32.4%).
With ≤ 12 pairwise SNP distances, 43.2% of L2.1 sufferers belong to MDR-TB or XDR-TB transmission clusters suggesting a excessive degree of clonal growth throughout 4 Thai provinces. All XDR-TB (100%) have been possible attributable to transmission quite than insufficient remedy. We discovered a 47 mutation signature and a partial deletion of the fadD14 gene within the circulating XDR-TB cluster, which can be utilized for surveillance of this uncommon and resilient M. tuberculosis strain-type that’s inflicting rising well being burden. We additionally detected three novel deletion positions, a deletion of 1,285 bp inside desA3 (Rv3230c), giant deletions within the plcB, plcA, and ppe38 gene which can play a job within the virulence, pathogenesis or evolution of the L2.1 strain-type.
The Veterans Affairs Precision Oncology Information Repository, a Medical, Genomic, and Imaging Analysis Database
The Veterans Affairs Precision Oncology Information Repository (VA-PODR) is a big, nationwide repository of de-identified knowledge on sufferers recognized with most cancers on the Division of Veterans Affairs (VA). Information embrace longitudinal scientific knowledge from the VA’s nationwide digital well being file system and the VA Central Most cancers Registry, focused tumor sequencing knowledge, and medical imaging knowledge together with computed tomography (CT) scans and pathology slides.
A subset of the repository is out there on the Genomic Information Commons (GDC) and The Most cancers Imaging Archive (TCIA), and the total repository is out there by means of the Veterans Precision Oncology Information Commons (VPODC). By releasing this de-identified dataset, we goal to advance Veterans’ well being care by means of enabling translational analysis on the Veteran inhabitants by all kinds of researchers.
Uncovering Efficient Explanations for Interactive Genomic Information Evaluation
Higher instruments are wanted to allow researchers to shortly establish and discover efficient and interpretable feature-based explanations for discriminating multi-class genomic datasets, e.g., wholesome versus diseased samples. We develop an interactive exploration instrument, GENVISAGE, which quickly discovers essentially the most discriminative function pairs that separate two courses of genomic objects after which shows the corresponding visualizations.
Since shortly discovering prime function pairs is computationally difficult, particularly for big numbers of objects and options, we suggest a collection of optimizations to make GENVISAGE responsive at scale and reveal that our optimizations result in a 400× speedup over aggressive baselines for a number of organic datasets. We apply our speedy and interpretable instrument to establish literature-supported pairs of genes whose transcriptomic responses considerably discriminate a number of chemotherapy drug therapies. With its generalizable optimizations and framework, GENVISAGE opens up real-time feature-based clarification era to knowledge from large sequencing efforts, in addition to many different scientific domains.
Genomics of Human Fibrotic Illnesses: Disordered Wound Therapeutic Response
Fibrotic illness, which is implicated in virtually half of all deaths worldwide, is the results of an uncontrolled wound therapeutic response to harm wherein tissue is changed by deposition of extra extracellular matrix, resulting in fibrosis and lack of organ operate. A plethora of genome-wide affiliation research, microarrays, exome sequencing research, DNA methylation arrays, next-generation sequencing, and profiling of noncoding RNAs have been carried out in patient-derived fibrotic tissue, with the shared aim of using genomics to establish the transcriptional networks and organic pathways underlying the event of fibrotic illnesses.
On this evaluate, we talk about fibrosing issues of the pores and skin, liver, kidney, lung, and coronary heart, systematically (1) characterizing the preliminary acute harm that drives unresolved irritation, (2) figuring out genomic research which have outlined the pathologic gene modifications resulting in extra matrix deposition and fibrogenesis, and (3) summarizing therapies concentrating on pro-fibrotic genes and networks recognized within the genomic research. In the end, profitable bench-to-bedside translation of observations from genomic research will end result within the growth of novel anti-fibrotic therapeutics that enhance practical high quality of life for sufferers and reduce mortality from fibrotic illnesses.
Genomic choice for heterobothriosis resistance concurrent with physique measurement within the tiger pufferfish, Takifugu rubripes
Parasite resistance traits in aquaculture species typically have average heritability, indicating the potential for genetic enhancements by selective breeding. Nonetheless, parasite resistance is commonly synonymous with an undesirable unfavourable correlation with physique measurement. On this research, we first examined the feasibility of genomic choice (GS) on resistance to heterobothriosis, brought on by the monogenean parasite Heterobothrium okamotoi, which results in enormous financial losses in aquaculture of the tiger pufferfish Takifugu rubripes.
Then, utilizing a simulation research, we examined the potential for simultaneous enchancment of parasite resistance, assessed by parasite counts on host fish (HC), and commonplace size (SL). Every trait confirmed average heritability (square-root remodeled HC: h2 = 0.308 ± 0.123, S.E.; SL: h2 = 0.405 ± 0.131). The predictive skills of genomic prediction amongst 12 fashions, together with genomic Finest Linear Unbiased Predictor (GBLUP), Bayesian regressions, and machine studying procedures, have been additionally average for each remodeled HC (0.248‒0.344) and SL (0.340‒0.481).
 Neisseria meningitidis RT PCR kit |
|
RTq-H421-100D |
Bioingentech |
100T |
EUR 717 |
Neisseria meningitidis RT PCR kit |
|
RTq-H421-150D |
Bioingentech |
150T |
EUR 808 |
Neisseria meningitidis RT PCR kit |
|
RTq-H421-50D |
Bioingentech |
50T |
EUR 598 |
) Neisseria meningitidis serogroup B / serotype 15 Major outer membrane protein P.IB (porB) |
|
1-CSB-EP518750NGH |
Cusabio |
-
EUR 611.00
-
EUR 309.00
-
EUR 1827.00
-
EUR 939.00
-
EUR 1218.00
-
EUR 397.00
|
-
100ug
-
10ug
-
1MG
-
200ug
-
500ug
-
50ug
|
|
|
|
Description: Recombinant Neisseria meningitidis serogroup B / serotype 15 Major outer membrane protein P.IB(porB) expressed in E.coli |
 Neisseria meningitidis antigen Orf1 / FrpD Antibody |
|
abx140046-01mg |
Abbexa |
0.1 mg |
EUR 425 |
|
|
 Neisseria meningitidis One-Step PCR kit |
|
Oneq-H421-100D |
Bioingentech |
100T |
EUR 866 |
Neisseria meningitidis One-Step PCR kit |
|
Oneq-H421-150D |
Bioingentech |
150T |
EUR 981 |
Neisseria meningitidis One-Step PCR kit |
|
Oneq-H421-50D |
Bioingentech |
50T |
EUR 718 |
) Neisseria meningitidis serogroup B Transferrin-binding protein 1 (tbp1) |
|
1-CSB-EP881449NGG |
Cusabio |
-
EUR 611.00
-
EUR 309.00
-
EUR 1827.00
-
EUR 939.00
-
EUR 1218.00
-
EUR 397.00
|
-
100ug
-
10ug
-
1MG
-
200ug
-
500ug
-
50ug
|
|
|
|
Description: Recombinant Neisseria meningitidis serogroup B Transferrin-binding protein 1(tbp1),partial expressed in E.coli |
) Neisseria meningitidis serogroup B Penicillin-binding protein 1A (mrcA) |
|
1-CSB-EP363014NGG |
Cusabio |
-
EUR 611.00
-
EUR 309.00
-
EUR 1827.00
-
EUR 939.00
-
EUR 1218.00
-
EUR 397.00
|
-
100ug
-
10ug
-
1MG
-
200ug
-
500ug
-
50ug
|
|
|
|
Description: Recombinant Neisseria meningitidis serogroup B Penicillin-binding protein 1A(mrcA),partial expressed in E.coli |
) Neisseria meningitidis serogroup B Major outer membrane protein P.IA (porA) |
|
1-CSB-EP320687NGG |
Cusabio |
-
EUR 611.00
-
EUR 309.00
-
EUR 1827.00
-
EUR 939.00
-
EUR 1218.00
-
EUR 397.00
|
-
100ug
-
10ug
-
1MG
-
200ug
-
500ug
-
50ug
|
|
|
|
Description: Recombinant Neisseria meningitidis serogroup B Major outer membrane protein P.IA(porA) expressed in E.coli |
) Neisseria meningitidis serogroup B Major outer membrane protein P.IB (porB) |
|
1-CSB-EP326992NBK |
Cusabio |
-
EUR 611.00
-
EUR 309.00
-
EUR 1827.00
-
EUR 939.00
-
EUR 1218.00
-
EUR 397.00
|
-
100ug
-
10ug
-
1MG
-
200ug
-
500ug
-
50ug
|
|
|
|
Description: Recombinant Neisseria meningitidis serogroup B Major outer membrane protein P.IB(porB) expressed in E.coli |
Neisseria meningitidis serogroup B Major outer membrane protein P.IB (porB) |
|
1-CSB-EP329012NBK |
Cusabio |
-
EUR 611.00
-
EUR 309.00
-
EUR 1827.00
-
EUR 939.00
-
EUR 1218.00
-
EUR 397.00
|
-
100ug
-
10ug
-
1MG
-
200ug
-
500ug
-
50ug
|
|
|
|
Description: Recombinant Neisseria meningitidis serogroup B Major outer membrane protein P.IB(porB) expressed in E.coli |
Neisseria meningitidis serogroup B Major outer membrane protein P.IB (porB) |
|
1-CSB-EP333550NGG |
Cusabio |
-
EUR 611.00
-
EUR 309.00
-
EUR 1827.00
-
EUR 939.00
-
EUR 1218.00
-
EUR 397.00
|
-
100ug
-
10ug
-
1MG
-
200ug
-
500ug
-
50ug
|
|
|
|
Description: Recombinant Neisseria meningitidis serogroup B Major outer membrane protein P.IB(porB) expressed in E.coli |
Neisseria meningitidis serogroup B Major outer membrane protein P.IB (porB) |
|
1-CSB-EP335569NBK |
Cusabio |
-
EUR 611.00
-
EUR 309.00
-
EUR 1827.00
-
EUR 939.00
-
EUR 1218.00
-
EUR 397.00
|
-
100ug
-
10ug
-
1MG
-
200ug
-
500ug
-
50ug
|
|
|
|
Description: Recombinant Neisseria meningitidis serogroup B Major outer membrane protein P.IB(porB) expressed in E.coli |
 N. Meningitidis Antibody |
|
abx023104-1ml |
Abbexa |
1 ml |
EUR 599 |
|
|
) N. Meningitidis Antibody (FITC) |
|
abx023103-1ml |
Abbexa |
1 ml |
EUR 599 |
|
|
 Purified) Anti-Orf1 (N. meningitidis) Purified |
|
11-489-C025 |
ExBio |
0.025 mg |
EUR 122 |
Anti-Orf1 (N. meningitidis) Purified |
|
11-489-C100 |
ExBio |
0.1 mg |
EUR 204 |
) Listeria monocytogenes serotype 4b Internalin-A (inlA) |
|
1-CSB-YP758331LAAD |
Cusabio |
-
EUR 679.00
-
EUR 335.00
-
EUR 2172.00
-
EUR 1051.00
-
EUR 1442.00
-
EUR 435.00
|
-
100ug
-
10ug
-
1MG
-
200ug
-
500ug
-
50ug
|
|
|
|
Description: Recombinant Listeria monocytogenes serotype 4b Internalin-A(inlA),partial expressed in Yeast |
 Human rhinovirus A serotype 89 Genome polyprotein |
|
1-CSB-YP362073HQD |
Cusabio |
-
EUR 430.00
-
EUR 234.00
-
EUR 1508.00
-
EUR 642.00
-
EUR 1009.00
-
EUR 291.00
|
-
100ug
-
10ug
-
1MG
-
200ug
-
500ug
-
50ug
|
|
|
|
Description: Recombinant Human rhinovirus A serotype 89 Genome polyprotein,partial expressed in Yeast |
Human rhinovirus A serotype 89 Genome polyprotein |
|
1-CSB-EP362073HQD |
Cusabio |
-
EUR 380.00
-
EUR 214.00
-
EUR 1309.00
-
EUR 560.00
-
EUR 873.00
-
EUR 262.00
|
-
100ug
-
10ug
-
1MG
-
200ug
-
500ug
-
50ug
|
|
|
|
Description: Recombinant Human rhinovirus A serotype 89 Genome polyprotein,partial expressed in E.coli |
Human rhinovirus A serotype 89 Genome polyprotein |
|
1-CSB-EP362073HQDb0 |
Cusabio |
-
EUR 380.00
-
EUR 214.00
-
EUR 1309.00
-
EUR 560.00
-
EUR 873.00
-
EUR 262.00
|
-
100ug
-
10ug
-
1MG
-
200ug
-
500ug
-
50ug
|
|
|
|
Description: Recombinant Human rhinovirus A serotype 89 Genome polyprotein,partial expressed in E.coli |
Listeria monocytogenes serotype 4b Internalin-A (inlA) |
|
1-CSB-EP758331LAAD |
Cusabio |
-
EUR 611.00
-
EUR 309.00
-
EUR 1827.00
-
EUR 939.00
-
EUR 1218.00
-
EUR 397.00
|
-
100ug
-
10ug
-
1MG
-
200ug
-
500ug
-
50ug
|
|
|
|
Description: Recombinant Listeria monocytogenes serotype 4b Internalin-A(inlA) ,partial expressed in E.coli |
 Rhinovirus A serotype 89 Genome polyprotein Antibody |
|
20-abx109372 |
Abbexa |
-
EUR 411.00
-
EUR 1845.00
-
EUR 599.00
-
EUR 182.00
-
EUR 300.00
|
-
100 ug
-
1 mg
-
200 ug
-
20 ug
-
50 ug
|
|
|
) Rhinovirus A serotype 89 Genome polyprotein Antibody (FITC) |
|
20-abx107303 |
Abbexa |
-
EUR 411.00
-
EUR 1845.00
-
EUR 599.00
-
EUR 182.00
-
EUR 300.00
|
-
100 ug
-
1 mg
-
200 ug
-
20 ug
-
50 ug
|
|
|
) Rhinovirus A serotype 89 Genome polyprotein Antibody (HRP) |
|
20-abx108723 |
Abbexa |
-
EUR 411.00
-
EUR 1845.00
-
EUR 599.00
-
EUR 182.00
-
EUR 300.00
|
-
100 ug
-
1 mg
-
200 ug
-
20 ug
-
50 ug
|
|
|
 peptid IgG, aff pure) Goat Anti-Human Apolipoprotein A-IV A(ApoA4) peptid IgG, aff pure |
|
APOA45-A |
Alpha Diagnostics |
100 ul |
EUR 482 |
 peptide IgG, aff pure) Rabbit Anti-Foot and mouth disease virus serotype O, 2A (FMDO-2A) peptide IgG, aff pure |
|
FMDO2A11-A |
Alpha Diagnostics |
100 ug |
EUR 482 |
 IgG) Rabbit Anti-human MART-1/Melanocyte Differentiation-A/Melan-A peptide (CT) IgG |
|
MART12-A |
Alpha Diagnostics |
100 ul |
EUR 445 |
 Boc-a-Me-DL-Val-OH |
|
A-4145.0001 |
Bachem |
1.0g |
EUR 139 |
|
Description: Sum Formula: C11H21NO4; CAS# [139938-00-4] |
Boc-a-Me-DL-Val-OH |
|
A-4145.0005 |
Bachem |
5.0g |
EUR 477 |
|
Description: Sum Formula: C11H21NO4; CAS# [139938-00-4] |
 (A/Wyoming/3/03) protein IgG, aff pure) Rabbit Anti-Influenza A HA (H1N1, 1-343aa) (A/Wyoming/3/03) protein IgG, aff pure |
|
H3N22-A |
Alpha Diagnostics |
100 ul |
EUR 445 |
-OH) Fmoc-a-amino-DL-Gly(Boc)-OH |
|
A-4320.0001 |
Bachem |
1.0g |
EUR 273 |
|
Description: Sum Formula: C22H24N2O6; CAS# [176039-39-7] |
Fmoc-a-amino-DL-Gly(Boc)-OH |
|
A-4320.0005 |
Bachem |
5.0g |
EUR 998 |
|
Description: Sum Formula: C22H24N2O6; CAS# [176039-39-7] |
 Serotype A PCR kit) Foot-and-Mouth Disease Virus (FMDV) Serotype A PCR kit |
|
PCR-V136-48R |
Bioingentech |
50T |
EUR 823 |
Foot-and-Mouth Disease Virus (FMDV) Serotype A PCR kit |
|
PCR-V136-96R |
Bioingentech |
100T |
EUR 1113 |
 Foot-and-Mouth Disease Virus Serotype A GVII PCR kit |
|
PCR-V583-48R |
Bioingentech |
50T |
EUR 823 |
Foot-and-Mouth Disease Virus Serotype A GVII PCR kit |
|
PCR-V583-96R |
Bioingentech |
100T |
EUR 1113 |
 protein (A/06/California/2009) IgG, aff pure) Rabbit Anti-Influenza A nucleoprotein (H1N1-NP/1-320aa) protein (A/06/California/2009) IgG, aff pure |
|
H1NP21-A |
Alpha Diagnostics |
100 ul |
EUR 445 |
 (A/Vietnam/1203/2004 366-531aa, >95%, his-tag) protein IgG) Rabbit Anti-Influenza A HA2 (H5N1) (A/Vietnam/1203/2004 366-531aa, >95%, his-tag) protein IgG |
|
HA2H012-A |
Alpha Diagnostics |
100 ul |
EUR 445 |
 (A/Brisbane/10/2007) protein IgG, aff pure) Rabbit Anti-Influenza A HA (H3N2, 1-531aa/HA1+HA2) (A/Brisbane/10/2007) protein IgG, aff pure |
|
H3N23-A |
Alpha Diagnostics |
100 ul |
EUR 445 |
 IgG) Goat Anti-Hepatitis A Virus (Strain HM175) IgG |
|
HAV11-A |
Alpha Diagnostics |
100 ul |
EUR 457 |
 antiserum) Goat Anti-human Serum Amyloid A (SAA) antiserum |
|
SAA11-A |
Alpha Diagnostics |
100 ul |
EUR 482 |
) Streptococcus pyogenes serotype M5 M protein, serotype 5 (emm5) |
|
1-CSB-EP355917SMY |
Cusabio |
-
EUR 611.00
-
EUR 309.00
-
EUR 1827.00
-
EUR 939.00
-
EUR 1218.00
-
EUR 397.00
|
-
100ug
-
10ug
-
1MG
-
200ug
-
500ug
-
50ug
|
|
|
|
Description: Recombinant Streptococcus pyogenes serotype M5 M protein, serotype 5(emm5) expressed in E.coli |
 Rabbit Anti-Human Calcineurin A-subunit IgG aff pure |
|
CALNA12-A |
Alpha Diagnostics |
100 ug |
EUR 482 |
 Neisseria gonorrhoeae protein |
|
30-1875 |
Fitzgerald |
1 ml |
EUR 535 |
|
Description: Purified Native Neisseria gonorrhoeae protein |
 Neisseria gonorrhoeae antibody |
|
20C-CR2125RP |
Fitzgerald |
1 ml |
EUR 554 |
|
Description: Rabbit polyclonal Neisseria gonorrhoeae antibody |
Neisseria gonorrhoeae antibody |
|
10-1329 |
Fitzgerald |
1 mg |
EUR 259 |
|
Description: Mouse monoclonal Neisseria gonorrhoeae antibody |
Neisseria gonorrhoeae antibody |
|
10-1330 |
Fitzgerald |
1 mg |
EUR 259 |
|
Description: Mouse monoclonal Neisseria gonorrhoeae antibody |
 Neisseria Gonorrhoeae Antibody |
|
10-2759 |
Fitzgerald |
500 ug |
EUR 219 |
|
Description: Monoclonal Neisseria Gonorrhoeae Antibody |
Neisseria Gonorrhoeae Antibody |
|
10-2760 |
Fitzgerald |
500 ug |
EUR 219 |
|
Description: Monoclonal Neisseria Gonorrhoeae Antibody |
Neisseria Gonorrhoeae Antibody |
|
10-2761 |
Fitzgerald |
500 ug |
EUR 219 |
|
Description: Monoclonal Neisseria Gonorrhoeae Antibody |
Neisseria gonorrhoeae antibody |
|
10-N10A |
Fitzgerald |
500 ug |
EUR 489 |
|
Description: Mouse monoclonal Neisseria gonorrhoeae antibody |
Neisseria gonorrhoeae antibody |
|
10-N10B |
Fitzgerald |
500 ug |
EUR 489 |
|
Description: Mouse monoclonal Neisseria gonorrhoeae antibody |
Neisseria gonorrhoeae antibody |
|
20-NR08 |
Fitzgerald |
1 mg |
EUR 140 |
|
Description: Rabbit polyclonal Neisseria gonorrhoeae antibody |
Neisseria gonorrhoeae antibody |
|
10R-7778 |
Fitzgerald |
500 ug |
EUR 532 |
|
Description: Mouse monoclonal Neisseria gonorrhoeae antibody |
 Neisseria Gonorrhea Antibody |
|
20-abx137075 |
Abbexa |
|
|
|
|
Neisseria Gonorrhoeae Antibody |
|
abx022105-02mg |
Abbexa |
0.2 mg |
EUR 676 |
|
|
Neisseria Gonorrhoeae Antibody |
|
abx022106-1mg |
Abbexa |
1 mg |
EUR 913 |
|
|
Neisseria Gonorrhoeae Antibody |
|
abx022107-02mg |
Abbexa |
0.2 mg |
EUR 676 |
|
|
Neisseria Gonorrhoeae Antibody |
|
abx022108-1mg |
Abbexa |
1 mg |
EUR 982 |
|
|
Neisseria Gonorrhoeae Antibody |
|
abx023101-1ml |
Abbexa |
1 ml |
EUR 599 |
|
|
 Neisseria gonorrhoeae Antibody |
|
abx023851-1mg |
Abbexa |
1 mg |
EUR 1066 |
|
|
Neisseria gonorrhoeae Antibody |
|
abx023852-1mg |
Abbexa |
1 mg |
EUR 1066 |
|
|
Neisseria gonorrhoeae Antibody |
|
abx023853-1mg |
Abbexa |
1 mg |
EUR 1066 |
|
|
 Serotype A RT PCR kit) Foot-and-Mouth Disease Virus (FMDV) Serotype A RT PCR kit |
|
RTq-V136-100R |
Bioingentech |
100T |
EUR 1311 |
Foot-and-Mouth Disease Virus (FMDV) Serotype A RT PCR kit |
|
RTq-V136-150R |
Bioingentech |
150T |
EUR 1787 |
Foot-and-Mouth Disease Virus (FMDV) Serotype A RT PCR kit |
|
RTq-V136-50R |
Bioingentech |
50T |
EUR 963 |
 Foot-and-Mouth Disease Virus Serotype A GVII RT PCR kit |
|
RTq-V583-100R |
Bioingentech |
100T |
EUR 1311 |
Foot-and-Mouth Disease Virus Serotype A GVII RT PCR kit |
|
RTq-V583-150R |
Bioingentech |
150T |
EUR 1787 |
Foot-and-Mouth Disease Virus Serotype A GVII RT PCR kit |
|
RTq-V583-50R |
Bioingentech |
50T |
EUR 963 |
 Rabbit Anti-Mouse a-1-Acid Glycoprotein IgG, aff pure |
|
A1AG18-A |
Alpha Diagnostics |
100 ug |
EUR 482 |
 Rabbit Anti-Rat a-1-Acid Glycoprotein IgG, aff pure |
|
A1AG19-A |
Alpha Diagnostics |
100 ug |
EUR 482 |
 Rabbit Anti-Human Apolipoprotein A-I protein IgG, aff pure |
|
APOA12-A |
Alpha Diagnostics |
100 ug |
EUR 482 |
 Rabbit Anti-Mouse Apolipoprotein A-I protein IgG, aff pure |
|
APOA13-A |
Alpha Diagnostics |
100 ug |
EUR 482 |
 Goat Anti-Human Apolipoprotein A-Il protein IgG, aff pure |
|
APOA21-A |
Alpha Diagnostics |
100 ug |
EUR 482 |
 protein, IgG) Goat Anti-Green Fluorescent Proteins (GFP, A. victoria) protein, IgG |
|
GFP11-A |
Alpha Diagnostics |
100 ul |
EUR 408 |
 Rabbit Anti-Rat/Human Orexin-A IgG # 1, aff pure |
|
OXA11-A |
Alpha Diagnostics |
100 ug |
EUR 482 |
 Rabbit Anti-Mouse prepro Orexin A IgG # 1, aff pure |
|
PPOX11-A |
Alpha Diagnostics |
100 ul |
EUR 482 |
 protein (A/Viet Nam/1203/2004(H5N1) IgG, aff pure) Rabbit Anti-Influenza A hemeagglutinin A2 (HA2/stem or stalk domain/347-523aa) protein (A/Viet Nam/1203/2004(H5N1) IgG, aff pure |
|
HA28-A |
Alpha Diagnostics |
100 ul |
EUR 445 |
 IgG) Rabbit Anti-Hemagglutinin HA1 Influenza A Virus (H11N2; A/duck/Yangzhou/906/2002) IgG |
|
H11N2-01-A |
Alpha Diagnostics |
100 ul |
EUR 482 |
 protein, IgG, aff pure) Rabbit Anti-bovine Calcineurin (A+B subunits) protein, IgG, aff pure |
|
CALN11-A |
Alpha Diagnostics |
100 ug |
EUR 482 |
 IgG, aff pure) Rabbit Anti-Borrelia burgdorferi Osp-A protein (OspA) IgG, aff pure |
|
OSPA12-A |
Alpha Diagnostics |
100 ul |
EUR 482 |
 Serotype 2 fimbriasubunit Antibody |
|
20-abx110520 |
Abbexa |
-
EUR 411.00
-
EUR 1845.00
-
EUR 599.00
-
EUR 182.00
-
EUR 300.00
|
-
100 ug
-
1 mg
-
200 ug
-
20 ug
-
50 ug
|
|
|
 (A/New Caledonia/20/99) IgG) Rabbit Anti-Hemagglutinin Influenza A Virus H1N1 H1 (H1N1) (A/New Caledonia/20/99) IgG |
|
H1N1-01-A |
Alpha Diagnostics |
100 ul |
EUR 482 |
 IgG #1, aff. pure) Rabbit Anti-Rat neurite outgrowth inhibitor (Nogo-A) IgG #1, aff. pure |
|
NogoA11-A |
Alpha Diagnostics |
100 ug |
EUR 482 |
 Goat Anti-Human/mouse/rat Insulin chain A peptide IgG, aff pure |
|
INSA21-A |
Alpha Diagnostics |
100 ul |
EUR 482 |
 Serotype A One-Step PCR kit) Foot-and-Mouth Disease Virus (FMDV) Serotype A One-Step PCR kit |
|
Oneq-V136-100R |
Bioingentech |
100T |
EUR 1610 |
Foot-and-Mouth Disease Virus (FMDV) Serotype A One-Step PCR kit |
|
Oneq-V136-150R |
Bioingentech |
150T |
EUR 2205 |
Foot-and-Mouth Disease Virus (FMDV) Serotype A One-Step PCR kit |
|
Oneq-V136-50R |
Bioingentech |
50T |
EUR 1175 |
 Foot-and-Mouth Disease Virus Serotype A GVII One-Step PCR kit |
|
Oneq-V583-100R |
Bioingentech |
100T |
EUR 1610 |
Foot-and-Mouth Disease Virus Serotype A GVII One-Step PCR kit |
|
Oneq-V583-150R |
Bioingentech |
150T |
EUR 2205 |
Foot-and-Mouth Disease Virus Serotype A GVII One-Step PCR kit |
|
Oneq-V583-50R |
Bioingentech |
50T |
EUR 1175 |
 IgG #1, Aff. Pure) Rabbit Anti-Rat Epithelial Na Channel alpha (ENAC-a) IgG #1, Aff. Pure |
|
ENACa11-A |
Alpha Diagnostics |
100 ug |
EUR 482 |
 IgG #2, aff. pure) Rabbit Anti-Human Neurite outgrowth inhibitor (Nogo A-C) IgG #2, aff. pure |
|
NogoA12-A |
Alpha Diagnostics |
100 ug |
EUR 482 |
 IgG) Goat Anti-Human recombinant Fetuin A (Alpha-2 HS-Glycoprotein, AHSG, A2HS) IgG |
|
FETB12-A |
Alpha Diagnostics |
100 ug |
EUR 482 |
) Neisseria gonorrhoeae antibody (FITC) |
|
61C-CR2125M2F |
Fitzgerald |
100 ug |
EUR 402 |
|
Description: Mouse monoclonal Neisseria gonorrhoeae antibody (FITC) |
) Neisseria Gonorrhoeae Antibody (Biotin) |
|
abx023098-1ml |
Abbexa |
1 ml |
EUR 599 |
|
|
) Neisseria Gonorrhoeae Antibody (HRP) |
|
abx023100-1ml |
Abbexa |
1 ml |
EUR 599 |
|
|
 Neisseria sp. PCR kit |
|
PCR-H422-96D |
Bioingentech |
100T |
EUR 572 |
 Neisseria gonorrhoeae PCR kit |
|
PCR-H450-48D |
Bioingentech |
50T |
EUR 453 |
Neisseria gonorrhoeae PCR kit |
|
PCR-H450-96D |
Bioingentech |
100T |
EUR 572 |
) Dengue NS1 protein (Serotype 1) |
|
80-1536 |
Fitzgerald |
100 ug |
EUR 1287 |
|
Description: Purified recombinant Dengue NS1 protein (Serotype 1) (His tag) |
) Dengue NS1 protein (Serotype 2) |
|
80-1537 |
Fitzgerald |
100 ug |
EUR 1263 |
|
Description: Purified recombinant Dengue NS1 protein (Serotype 2) (His tag) |
) Dengue VLP protein (Serotype 2) |
|
80-1538 |
Fitzgerald |
100 ug |
EUR 925 |
|
Description: Purified recombinant Dengue VLP protein (Serotype 2) (His tag) |
) Dengue NS1 protein (Serotype 3) |
|
80-1539 |
Fitzgerald |
100 ug |
EUR 1777 |
|
Description: Purified recombinant Dengue NS1 protein (Serotype 3) (His tag) |
) Dengue VLP protein (Serotype 3) |
|
80-1540 |
Fitzgerald |
100 ug |
EUR 1089 |
|
Description: Purified recombinant Dengue VLP protein (Serotype 3) (His tag) |
) Dengue NS1 protein (Serotype 4) |
|
80-1541 |
Fitzgerald |
100 ug |
EUR 1646 |
|
Description: Purified recombinant Dengue NS1 protein (Serotype 4) (His tag) |
Dengue NS1 protein (Serotype 1) |
|
30-1844 |
Fitzgerald |
250 ug |
EUR 408 |
|
Description: Purified recombinant Dengue NS1 protein (Serotype 1) |
Dengue NS1 protein (Serotype 3) |
|
30-1846 |
Fitzgerald |
250 ug |
EUR 408 |
|
Description: Purified recombinant Dengue NS1 protein (Serotype 3) |
Dengue NS1 protein (Serotype 4) |
|
30-1847 |
Fitzgerald |
250 ug |
EUR 408 |
|
Description: Purified recombinant Dengue NS1 protein (Serotype 4) |
Dengue NS1 protein (Serotype 2) |
|
30-1909 |
Fitzgerald |
250 ug |
EUR 408 |
|
Description: Purified recombinant Dengue NS1 protein (Serotype 2) |
) Serotype 2 fimbriasubunit Antibody (Biotin) |
|
20-abx106239 |
Abbexa |
-
EUR 411.00
-
EUR 1845.00
-
EUR 599.00
-
EUR 182.00
-
EUR 300.00
|
-
100 ug
-
1 mg
-
200 ug
-
20 ug
-
50 ug
|
|
|
These outcomes confirmed the feasibility of GS for this trait. Though an undesirable genetic correlation was steered between remodeled HC and SL (rg = 0.228), the simulation research steered the specified good points index may help obtain simultaneous genetic enhancements in each traits.
)